Wisconsin Alumni Research Foundation
VC Fund
Madison, United States
Wisconsin Alumni Research Foundation is a VC fund in Madison focused on Health Care and Biotechnology. WARF) is the private, nonprofit patent and licensing organization for the University of Wisconsin–Madison, one of the world’s great research universities. WARF was founded in 1925 and is a pioneer and innovator among university-based technology transfer offices.WARF’s mission is to support, aid and encourage UW–Madison research by protectingits discoveries and licensing them to commercial partners for beneficial use in the real world. It is best known for commercializing groundbreaking vitamin D therapies, the revolutionary anticoagulant Coumadin®, innovative medical imaging and cancer radiation systems, and its patents for human embryonic stem cells.
- Total investments:
- 47
- Last investment:
- Lead investor:
- 15%
Last updated:
For AI agents: llms.txt
Industries Wisconsin Alumni Research Foundation invests in
Stages Wisconsin Alumni Research Foundation invests in
Countries Wisconsin Alumni Research Foundation invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Mike Partsch
|
|||
Andrew Morgan
|
|||
John Gransee
|
|||
Investment Focus
Industry
- Health Care 13 (28%)
- Biotechnology 11 (23%)
- Medical 4 (9%)
- Medical Device 4 (9%)
- Pharmaceutical 3 (6%)
Stage
- Series A 10 (21%)
- Seed 7 (15%)
- Series B 6 (13%)
- Funding Round 5 (11%)
- Grant 1 (2%)
Country
- United States 26 (55%)
- United Kingdom 1 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Mike Partsch
Chief Venture Officer
|
Chief Venture Officer | Total investments: 1 | Find email | |
|
Andrew Morgan
Pharmaceutical Catalyst
|
Pharmaceutical Catalyst | Total investments: 0 | Find email | |
|
John Gransee
Chief Operating Officer; Chief Financial Officer
|
Chief Operating Officer; Chief Financial Officer | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Qolab
|
Qolab mission is to build high quality qubits by leveraging the most advanced semiconductor manufacturing processes. | $54.2M / Series B / Jul 02, 2026 | |
Neuraworx Medical Technology
|
Neuraworx Medical Technology is a neurotechnology company developing first-in-class bioelectronic solutions for brain health. | Seed / Dec 18, 2025 | |
C-Motive Technologies
|
C-Motive Technologies focuses on reinventing the electric motor. Its motors run on the principle of electrostatic forces, also known as "static cling," and stands to change the machines that shape and run people's lives. Founded by Dan Ludois and Justin Reed in 2012, C-Motive Technologies is headquartered in Madison, Wisconsin. | $13.5M / Venture - Series Unknown / Jun 04, 2025 | |
Realta Fusion
|
Realta Fusion develops fusion energy technology for the production of industrial heat and power. It applies advances in super-conducting materials, plasma physics, and computing power to a simple linear fusion reactor configuration. It utilizes abundant fuel sources to provide a zero-carbon source of heat and power. | $36M / Series A / May 13, 2025 | |
|
Qolab
|
Qolab mission is to build high quality qubits by leveraging the most advanced semiconductor manufacturing processes. | $16M / Series A / Dec 20, 2024 | |
Leo Cancer Care
|
Leo Cancer Care develops radiation therapy technologies that support cancer treatment in an upright patient position. The company designs integrated imaging, patient positioning, and treatment systems that are compatible with fixed radiation beam platforms used in photon and particle therapy. Its technology focuses on supporting the radiotherapyworkflow from patient simulation through treatment while enabling multiple radiation therapy modalities. Leo Cancer Care also collaborates with healthcare providers, research institutions, and industry partners to evaluate and advance the clinical use of upright radiotherapy systems. In addition to developing treatment technologies, the company works on expanding access to radiotherapy through solutions that aim to improve workflow efficiency and compatibility with existing treatment infrastructure. | Series C / Jun 11, 2024 | |
Alithic
|
Alithic offers carbon-negative supplementary cementitious material solutions with no green premium. | $2M / Pre-Seed / Jan 01, 2024 | |
Ubicept
|
Ubicept is a computer vision company. They provide machine learning services by combining next-generation image sensors with computer vision algorithms. Their products include photon-counting cameras, edge photon processing, and a private developer portal. | $8M / Seed / Jul 25, 2023 | |
|
Realta Fusion
|
Realta Fusion develops fusion energy technology for the production of industrial heat and power. It applies advances in super-conducting materials, plasma physics, and computing power to a simple linear fusion reactor configuration. It utilizes abundant fuel sources to provide a zero-carbon source of heat and power. | $9M / Seed / May 31, 2023 | |
Pyran Inc.
|
Pyran is turning renewable paints and plastics from dreams into reality. | $1.5M / Series A / Mar 13, 2023 | |
| See all 47 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Wisconsin Alumni Research Foundation invest in?
Wisconsin Alumni Research Foundation invests primarily in Health Care, Biotechnology and Medical startups, most often at Series A and Seed stage. Most of the 47 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Wisconsin Alumni Research Foundation?
Public channels for Wisconsin Alumni Research Foundation include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Wisconsin Alumni Research Foundation?
The team at Wisconsin Alumni Research Foundation includes Mike Partsch (Chief Venture Officer), Andrew Morgan (Pharmaceutical Catalyst) and John Gransee (Chief Operating Officer; Chief Financial Officer). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
